New York, NY, United States of America

Irina Jilishitz

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Cornell University, Tri-Institutional Therapeutics Discovery Institute. Active years: 2024.


% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irina Jilishitz: Innovator in Pharmaceutical Compounds

Introduction

Irina Jilishitz is a notable inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. Her work is characterized by a focus on innovative solutions for treating fibrotic diseases and related disorders.

Latest Patents

Irina holds a patent for "Pyridinone- and pyridazinone-based compounds and uses thereof." This patent includes compounds of the formula A-L-Het-L-Cy, or a pharmaceutical acceptable salt, polymorph, prodrug, solvate, or clathrate thereof. The compounds are designed to be useful in the treatment of fibrotic diseases, abnormal vascular leak, and pathological angiogenesis. She has 1 patent to her name, showcasing her innovative approach to pharmaceutical development.

Career Highlights

Throughout her career, Irina has worked with prestigious institutions such as Cornell University and the Tri-Institutional Therapeutics Discovery Institute. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Irina has collaborated with notable colleagues, including Yasufimi Wada and William J. Polvino. These partnerships have further enhanced her research and development efforts in the pharmaceutical sector.

Conclusion

Irina Jilishitz is a pioneering inventor whose work in pharmaceutical compounds has the potential to make a significant impact on the treatment of various medical conditions. Her innovative spirit and dedication to research continue to drive advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…